The Indxx Global Generics & New Pharma Index provides exposure to the 40 largest companies involved in manufacturing Generics, SuperGenerics, Biobetters and Biosimilars, and providing API manufacturing, CMO and CRO services to the pharmaceutical industry. The index has been backtested to March 18, 2005 and has a live calculation date of November 13, 2015.
Index Characteristics
| Base Date | 03/21/2005 |
| No. of Constituents | 23 |
| Dividend Yield * |
1.07% |
| 52 Week High/Low ** |
4420/3479 |
| Company Name | Weight(%) |
|---|---|
| Iqvia Holdings Ord | 7.90% |
| Lonza Group Ord | 7.37% |
| Samsung Biolog Ord | 7.18% |
| Icon Ord | 6.91% |
| Celltrion Ord | 6.17% |
| Statistic | QTD | YTD | 1 Year | 3 Year | Since Base Date |
|---|---|---|---|---|---|
| Beta 1 |
NA | NA2 | NA | NA | NA |
| Correlation 1 |
NA | NA | NA | NA | NA |
| Returns 2 |
-2.15% | -4.19% | 8.27% | -1.82% | 7.57% |
| Standard Deviation | NA | 13.33% | 16.25% | 16.18% | 14.98% |